PANDORA CIG
@stratagem_cost
Followers
775
Following
75
Media
70
Statuses
215
COST Innovator Grant 17104: Pan-European Educational Platform on Multidrug Resistant Tumours and Personalised Cancer Treatment
EU
Joined September 2019
📌Save the Dates for the Upcoming Series of 3️⃣ "Meet the Experts" Online Round Tables. 🔘1️⃣MDR from bedside to bench and back.🗓️6 Oct, 14 CET.🔘2️⃣ Science, policy and economy: a complex liaison.🗓️10 Oct, 14 CET.🔘3️⃣ Road to success in biotech and pharma companies.🗓️17 Oct, 14 CET
1
0
0
🌍 The #COVID-19 Task Force among COST Actions resulted in publications, software, databases, and hygiene solutions, adopted worldwide. 🎙 Hear the story of how it all began, told by Prof. Chiara Riganti, Chair of STRATAGEM and PandoraCIG.@COSTprogramme
0
0
4
🔍 Are you ready to embark on the "#Road to #Success in #Biotech and #Pharma Companies"? Join our #concluding #event on 📅 October 17th 14:00 CET to hear from industry experts, gain insights, and connect with like-minded professionals. 🌠 🔗 @COSTprogramme.
stratagem-cost.eu
Round table 3: Road to success in biotech and pharma companies - Interactive online event 17th October 2023, 14-17 CEST Topics: challenges in running your own business outside academies:...
0
0
0
RT @CorbetCyril: Thrilled to share our last paper @CellReports ! .Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells….
cell.com
Vander Linden et al. show that cancer cell exposure to the glycolytic inhibitor 3-bromopyruvate leads to DNA methylation-dependent silencing of MCT1, the main entry path for this drug. Resistant...
0
12
0
RT @BilgeGTuna: I participated in CIG PANDORA COST training school in University of Ramon Llull in Barcelona. I had opportunity to give two….
0
2
0
A talk, showing the #StratagemCOST and #PandoraCIG's potential as #collaboration #starters was held by Dr. Yordan Yordanov. It was on the #preclinical characterization of a promising #novel subclass of promising H2S-releasing #anthracyclines. @WCP2023 @COSTprogramme @MedUniSofia
0
0
1
Prof. Elisa Giovanetti with a talk on #therapeutic #resistence in #pancreatic #cancer at @WCP2023 in Glasgow, Scotland!. @COSTprogramme; Medical University of Amsterdam
0
0
7
Prof. Bilge Guvenc Tuna is currently talking on the effect of #calorie #restriction in #miRNA, linked to MDR #tumours at @WCP2023 @YeditepeUni @BilgeGTuna
0
2
4
Prof. Bilge Guvenc Tuna is currently talking on the effect of #calorie #restriction in #miRNA, linked to MDR #tumours at @WCP2023 @YeditepeUni
0
1
2
Our Vice Chair Prof @jdelasrivas with a great talk about #computational #biology and #pharmacogenomics, part of our Workshop at @WCP2023 .@COSTprogramme @usal
0
1
2
Our Workshop at the @WCP2023 has been launched by prof. Chiara Riganti! Join us to learn more about the latest MDR cancer research. @COSTprogramme @unito
0
0
3
RT @COSTprogramme: Beating cancer requires a multidisciplinary & comprehensive approach. Collaboration is 🔑! . Thanks to the #COSTactions p….
0
5
0
👨🎓What: Liquid Biopsies: Searching for Cancer biomarkers.⏳ When: 15th June.🔗 Where: 👩🔬 Discover how #Liquid #Biopsies are Transforming #Cancer #Diagnosis and #Treatment through the Search for Valuable #Biomarkers. @COSTprogramme @UPorto @UnivdeCoimbra
0
0
0
RT @CFornagueraP: And finally, after learning #nanomedicines interaction with #biologicals, 🔚 of the #TS3 of the @stratagem_cost at @IQSbar….
0
4
0
RT @CFornagueraP: 2️⃣ Second day of the @stratagem_cost #TS3 finished. Today, our students learned how ro analyze and biophysically charact….
0
6
0
RT @CFornagueraP: ✔️ First day of the @stratagem_cost #TS3 finsihed! . 👩🏼🎓👨🏾🎓 Our attendees discovered and learned how to produce differe….
0
4
0
RT @CFornagueraP: 🏫 @stratagem_cost #Pandora’s Training School on the Preparation and Biophysical Characterization of Nanomedicines startin….
0
3
0
🚀 We are Gaining Momentum. 🔟 Successful #eLearning Modules so far.2️⃣ More on the Horizon! .3️⃣ #OnSite Trainings.3️⃣ Online #Meet the #Experts Events. 📌Don't Miss Out. @COSTprogramme @unito @SapienzaRoma @unisiena @MedUniSofia @usal @MedUni_Wien @UPorto.
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
0
0
🧬 💻Don't miss the exclusive opportunity to delve into @StateOfTheArt platforms, databases, and bioinformatics tools for scRNA sequencing:. 🗓️31st May 2023, 15:30 CEST.🔗 @jdelasrivas @usal @MedUni_Wien @genentech.#SingleCell #CancerResearch #DataAnalysis
0
1
2
RT @elisagiovan: Fibroblasts in pancreatic cancer: molecular and clinical perspectives - now online @TrendsMolecMed .
0
7
0